Inscobee Inc.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Seoul, Korea, Republic of
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Inscobee Inc.

Form 4 holding 10%+ Owner

Apimeds Pharmaceuticals US, Inc.

Security class
Convertible Promissory Note
Shares / value
0
Estimated value
Report date
12 May 2025
Price
Ownership
By Apimeds Inc.
Underlying class
Common Stock, par value $0.01 per share
Underlying amount

Insider Reports Filed by Inscobee Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .